One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias

Elizabeth Geddes-Bruce, Selina S. Hamill, Christopher B. Zachary, Paul Friedman

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Objectives: To evaluate the long-term efficacy of treating nasal telangiectasias with the TRASER device. Methods: Subjects from the TRASER efficacy analysis clinical trial were invited for a 1-year follow-up. Standardized photographs were taken to compare to baseline. The same clinical trial evaluator graded the subjects’ current vessel clearance using the 5-point telangiectasia scale. The data was compiled and analyzed. Results: Of the subjects with available follow-up data, 44% maintained “complete vessel clearance,” 44% dropped down one grade to “almost complete vessel clearance,” and 11% dropped down to “moderately clear vessel clearance.” All showed clinically significant improvement in nasal telangiectasias from baseline. Conclusions: The TRASER effectively treats nasal telangiectasias with minimal to mild recurrence at 1-year follow-up. Lasers Surg. Med. 50:61–63, 2018.

Original languageEnglish (US)
Pages (from-to)61-63
Number of pages3
JournalLasers in Surgery and Medicine
Issue number1
StatePublished - Jan 1 2018


  • laser
  • telangiectasias
  • vessels

ASJC Scopus subject areas

  • Surgery
  • Dermatology


Dive into the research topics of 'One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias'. Together they form a unique fingerprint.

Cite this